VaxThera, a leading Colombian company in science and technology, is dedicated to strengthening national health sovereignty, a strategic priority for the government. With state-of-the-art facilities, the company focuses on research, design, and production of high-quality vaccines and biologics, meeting the highest international standards.

In this ambitious endeavor, VaxThera has partnered with LabVantage as its technological ally. Leveraging its expertise, LabVantage supports VaxThera in optimizing laboratory processes, ensuring compliance with global regulations (FDA, EMA), and managing critical data. Together, they are positioning VaxThera as a key player in life sciences across Colombia and Latin America.

With cutting-edge technologies such as NRDA and recombinant vaccines, VaxThera, in partnership with LabVantage, establishes itself as a strategic force in addressing global health challenges.